Science and R&D

In an economy powered by innovation and technology, more proactive R&D policies are key to success.

Strengthening National Laboratory Commercialization

December 10, 2013 - 10:00am - 11:30am
Cannon House Office Building, Room 121
United States Capitol
Washington
DC
20510

Post-World War II era U.S. science, technology, and innovation policy has been defined by a linear approach to public investment in basic research. For many decades, this worked because the United States was one of the few countries with the technological capabilities to translate research into new products and services. Read more »

Strengthening National Laboratory Commercialization

December 10, 2013
This event evaluated the current technology transfer capabilities of the National Laboratories and the reforms needed to strengthen commercialization.

Post-World War II era U.S. science, technology, and innovation policy has been defined by a linear approach to public investment in basic research. For many decades, this worked because the United States was one of the few countries with the technological capabilities to translate research into new products and services. But in today’s intensely competitive global economy where nations are fiercely competing for innovation advantage, this paradigm is no longer tenable. Read more »

The Fiscal Cliff for University R&D

December 8, 2013
Robert Atkinson discussed America’s declining investment in university research on ABC7’s Government Matters.

Robert Atkinson discussed America’s declining investment in university research on ABC7’s Government Matters, the Washington, DC public affairs program.

University Research Funding: Still Lagging and Showing No Signs of Improvement

December 6, 2013
| Reports

It will come as a surprise to many that America is no longer, and nowhere near, the lead nation in terms of funding university research. In fact, of 39 nations, the U.S. ranks just 24th in government funding and 27th in business funding as a share of GDP. In fact, the leading seven nations invest more than double the U.S. level. The result over time will be a continued loss of U.S. competitiveness.

Enhancing Technology Commercialization through SBIR/STTR Reform

December 3, 2013 - 9:00am - 10:30am
Cannon House Office Building
United States Capitol
121
Washington
DC
20510

Post-World War II era U.S. science, technology, and innovation policy has been defined by a linear approach to public investment in basic research. For many decades, this policy worked because the United States was one of the few countries with the technological capabilities to translate research into new products and services. Read more »

Robust Federal Investment in Scientific Research Critical to Sustaining Moore’s Law

November 22, 2013
| Blogs & Op-eds

Moore’s Law may reach its limit by 2020. Foundational innovation in semiconductor electronics will be needed in both the public and private sector to insure computing power continues to advance and promote our future digital economy.

What The U.S. Can Learn From Denmark's Industrial PhD Program

November 20, 2013
| Blogs & Op-eds

Denmark’s industrial-focused doctorate can serve as a model for private sector-relevant education and research. The program is designed to increase knowledge sharing between universities and private sector companies, promote research with commercial perspectives, and increase the number of professional with Ph.Ds. in the Danish economy. 

Fixing the U.S. Budget Deficit

November 6, 2013
Robert Atkinson appeared on Bloomberg Radio’s Taking Stock to discuss policy reforms that can address the budget deficit without sacrificing growth inducing federal investments.

Robert Atkinson appeared on Bloomberg Radio’s Taking Stock to discuss policy reforms that can address the budget deficit without sacrificing growth inducing federal investments.

Universities as Innovation Engines: New Evidence

October 23, 2013
| Blogs & Op-eds

A new research paper compares patent applications from startup university spinoffs and finds they are more innovative than comparable firms, in part because of their stronger ties to research networks and close proximity to universities.